| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 166.59B | 164.68B | 159.51B | 152.67B | 157.40B | 151.16B |
| Gross Profit | 55.19B | 54.87B | 53.31B | 50.96B | 52.78B | 50.83B |
| EBITDA | 23.12B | 24.29B | 25.43B | 25.11B | 27.07B | 25.95B |
| Net Income | 14.01B | 14.16B | 14.81B | 15.14B | 17.11B | 16.43B |
Balance Sheet | ||||||
| Total Assets | 107.90B | 105.09B | 96.12B | 76.53B | 76.44B | 71.88B |
| Cash, Cash Equivalents and Short-Term Investments | 1.60B | 1.39B | 1.66B | 3.76B | 2.76B | 2.34B |
| Total Debt | 63.14B | 65.35B | 62.29B | 52.24B | 50.36B | 46.27B |
| Total Liabilities | 94.03B | 92.28B | 89.48B | 75.49B | 74.88B | 73.57B |
| Stockholders Equity | 13.87B | 12.81B | 6.64B | 1.04B | 1.56B | -1.70B |
Cash Flow | ||||||
| Free Cash Flow | 14.31B | 12.65B | 16.32B | 17.95B | 11.50B | 14.01B |
| Operating Cash Flow | 18.03B | 16.32B | 19.81B | 21.17B | 14.62B | 16.57B |
| Investing Cash Flow | -9.16B | -8.98B | -21.03B | -4.73B | -3.14B | -2.97B |
| Financing Cash Flow | -8.67B | -7.71B | -694.00M | -15.44B | -10.99B | -19.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $476.49B | 55.55 | 28.81% | 0.59% | 8.40% | 12.18% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | $309.35B | 23.60 | 113.30% | 2.67% | 2.23% | -4.48% | |
58 Neutral | $12.85B | 6.35 | 38.54% | 5.46% | 0.39% | 17.90% | |
58 Neutral | $16.64B | 35.89 | 42.57% | 1.80% | 4.64% | 1.15% | |
56 Neutral | $123.80B | 37.36 | -64.84% | 1.94% | 3.12% | -3.03% | |
53 Neutral | $5.08B | 35.69 | 8.38% | ― | 3.46% | -3.01% |